Poolbeg Pharma PLC (AIM: POLB)

Poolbeg Pharma Statistics

Total Valuation

Poolbeg Pharma has a market cap or net worth of GBP 55.50 million. The enterprise value is 43.33 million.

Market Cap	55.50M
Enterprise Value	43.33M

Important Dates

The next estimated earnings date is Friday, September 13, 2024.

Earnings Date	Sep 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Poolbeg Pharma has 500.00 million shares outstanding.

Shares Outstanding	500.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.93%
Owned by Institutions (%)	46.54%
Float	426.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.84
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.69

Current Ratio	13.69
Quick Ratio	13.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.00% and return on invested capital (ROIC) is -17.88%.

Return on Equity (ROE)	-24.00%
Return on Assets (ROA)	-16.87%
Return on Capital (ROIC)	-17.88%
Revenue Per Employee	n/a
Profits Per Employee	-262,067
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+57.45%
50-Day Moving Average	12.48
200-Day Moving Average	11.07
Relative Strength Index (RSI)	30.26
Average Volume (20 Days)	590,782

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.69M
Pretax Income	-4.51M
Net Income	-3.93M
EBITDA	-4.66M
EBIT	-4.69M
Earnings Per Share (EPS)	-0.01

Balance Sheet

Cash & Cash Equivalents	12.17M
Total Debt	n/a
Net Cash	12.17M
Net Cash Per Share	0.02
Equity (Book Value)	14.44M
Book Value Per Share	0.03
Working Capital	12.51M

Cash Flow

Operating Cash Flow	-4.38M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Poolbeg Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.12%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a